Clinical Trial Update: The Effect of Sacubitril/Valsartan on Cardiovascular Events in Dialysis Patients and Efficacy Prediction of Baseline LVEF Value [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the effect of sacubitril/valsartan on cardiovascular events in dialysis patients and predicting efficacy from baseline LVEF.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: Shenzhen Second People's Hospital | Conditions: Peritoneal Dialysis Complication, Hemodialysis Complication | Phase 4 | Status: UNKNOWN